Jean-Jacques Lebrun
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 29, 2025
A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer.Xueqing Liu, Alaa Moamer, Roger Gomes da Silva
|Jul 08, 2024
Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.Amina Jamal Laham, Raafat El-Awady, Maha Saber-Ayad
|Jun 05, 2024
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.Amina Jamal Laham, Raafat El-Awady, Maha Saber-Ayad
|Nov 06, 2023
Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance.Gang Yan, Meiou Dai, Sophie Poulet
|May 25, 2021
In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy.Meiou Dai, Gang Yan, Ni Wang
|Mar 02, 2021
TGFβ/cyclin D1/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity.Gang Yan, Meiou Dai, Chenjing Zhang
Pageof 2
